Sheran Sharafi

Sheran Sharafi

Sheran Sharafi
New York
+1 212 813 8965

Sheran Sharafi is an associate in Goodwin’s Business Law department and a member of its Life Sciences group and a member of its Public M&A/Corporate Governance practice. Sheran primarily represents public companies in mergers and acquisitions, securities offerings, corporate governance, and ’34 Act reporting and compliance matters.

Prior to joining Goodwin in 2021, Sheran was an associate in Reed Smith LLP’s New York office.


  • AVROBIO, Inc. (Nasdaq: AVRO) in its reverse merger with Tectonic Therapeutic, including contingent value rights (CVRs) and the concurrent private placement financing
  • Immunome Inc. (Nasdaq: IMNM) in its acquisition of certain assets of Atreca, Inc. (Nasdaq: BCEL) for $5.5 million upfront cash plus contingent value rights (CVRs)
  • EryDel in its cross-border sale to Quince Therapeutics
  • Graphite Bio, Inc. (Nasdaq: GRPH) in its reverse merger with LENZ Therapeutics and concurrent private placement financing
  • BioSight Ltd., an Israeli company, in its merger with Ayala Pharmaceuticals, Inc. (OTCQX: ADXS)
  • Ikena Oncology Inc.’s (Nasdaq: IKNA) acquisition of Pionyr Immunotherapeutics in an all-stock transaction and contingent value rights (CVRs)
  • AVROBIO’s (Nasdaq: AVRO) sale of its Cystinosis gene therapy program for $87.5 million to Novartis (NYSE: NVS)
  • TCR² Therapeutics (Nasdaq: TCRR) in its cross-border, all-stock combination with Adaptimmune Therapeutics (Nasdaq: ADAP)
  • Concert Pharmaceuticals in its sale to Sun Pharma for $576 million in upfront cash plus contingent value rights (CVRs)
  • BJ’s Wholesale Group in its acquisition of assets and operations of four distribution centers and the related private transportation fleet from Burris Logistics
  • Vaccitech plc (Nasdaq: VACC) in its $40 million acquisition of Avidea Technologies, Inc.
  • Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL) in its $2.26 billion sale to Pfizer Inc. (NYSE:PFE)
  • KushCo Holdings, Inc. (OTCQX: KSHB) in its merger with Greenlane Holdings, Inc. (NASDAQ: GNLN)*
  • Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) in its reverse merger with Qualigen, Inc.*
  • Venus Concept, Inc. in its reverse merger with Restoration Robotics, Inc. (Nasdaq:HAIR)*
  • Private company in the fashion industry in its $500 million acquisition of another fashion company and label*

* Denotes experience prior to joining Goodwin

Professional Activities

Sheran is a member of the New York Bar Association and the American Bar Association.




Boston University School of Law


Brooklyn College

(summa cum laude, Phi Beta Kappa)



  • New York

Recognition & Awards

Sheran was recognized as a New York Metro Rising Star by Super Lawyers in 2022-2023.


Co-Author, "The Attorney-Client Privilege Post-Merger," Law360, December 13, 2016